Print this page

Strategic brands post increases 

With one exception, the global sales of our five strategic brands developed positively, posting double-digit increases. The Bion® range generated global sales of EUR 54 million, an increase of 11%, of which France contributed the vast majority, or EUR 32 million. Femibion® grew by 24%, generating sales of EUR 41 million. Its strongest markets are Germany and Poland. France also recently reported strong increases. Seven Seas® recorded a slight sales decline of 1.4% in its core UK market. However, thanks to the positive developments in other countries, sales grew by a total of 14% to EUR 44 million. Nasivin® sales grew by 23% to EUR 52 million, driven primarily by good performance in Poland, Russia, South Africa and India. The Kytta® brand, which is primarily marketed in Germany, registered a 21% decline in sales to EUR 15 million. The development of Kytta in Germany was attributable to overproportionate increases in advertising spending by our competitors compared to 2009.

Top five brands by sales in 2010

Consumer Health Care – Top five brands by sales in 2010 (pie chart)
© Merck KGaA, Darmstadt, Germany, Last Update 2010/02/23